BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 14582670)

  • 1. Alopecia areata susceptibility in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Zöller M; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):182-7. PubMed ID: 14582670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
    McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
    J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of alopecia areata in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Sundberg JP; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):6-11. PubMed ID: 12894987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata.
    Zöller M; McElwee KJ; Engel P; Hoffmann R
    J Invest Dermatol; 2002 Jun; 118(6):983-92. PubMed ID: 12060392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata: a review of disease pathogenesis.
    Rajabi F; Drake LA; Senna MM; Rezaei N
    Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response.
    Tobin DJ
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):176-81. PubMed ID: 14582669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytes, neuropeptides, and genes involved in alopecia areata.
    Gilhar A; Paus R; Kalish RS
    J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata: autoimmunity--the evidence is compelling.
    Kalish RS; Gilhar A
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
    Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
    J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata - animal models.
    McElwee KJ; Hoffmann R
    Clin Exp Dermatol; 2002 Jul; 27(5):410-7. PubMed ID: 12190642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
    Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP
    J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of alopecia areata.
    Hordinsky MK
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
    Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lymphocytes in the development and treatment of alopecia areata.
    Guo H; Cheng Y; Shapiro J; McElwee K
    Expert Rev Clin Immunol; 2015; 11(12):1335-51. PubMed ID: 26548356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
    Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
    Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
    Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to hair follicles in alopecia areata.
    Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
    J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
    Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.